11/30/2020, 1:08 PM (Source: TeleTrader)
more TeleTrader news

Moderna's vaccine 94% effective, will request EUA today

Moderna Inc. confirmed on Monday that its coronavirus vaccine candidate is 94.1% effective in preventing the disease, and that it is set to ask regulators in the United States and Europe for an emergency use authorization (EUA) later today.

Commenting on the breakthrough, Chief Executive Stephane Bancel said that "this positive primary analysis confirms the ability of our vaccine to prevent COVID-19 disease with 94.1% efficacy and importantly, the ability to prevent severe COVID-19 disease. We believe that our vaccine will provide a new and powerful tool that may change the course of this pandemic and help prevent severe disease, hospitalizations and death."

The vaccine review conducted by the United States Food and Drug Administration (FDA) should last a couple of weeks, Moderna estimated, noting that an advisory committee meeting will likely take place on December 17.

Breaking the News / ND